DEFINITIVE PROXY STATEMENT

Company

Centessa Pharmaceuticals plc

Filed

May 9, 2024

Period of Report

June 25, 2024

Accession Number

0001839882-24-014966

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →